INTERNATIONAL PATENT: WAVERLEY PHARMA INC. FILES APPLICATION FOR "QUINAZOLINONE DERIVATIVES AS POLY (ADP RIBOSE) POLYMERASE 1 (PARP-1) INHIBITORS"

GENEVA, June 9 -- WAVERLEY PHARMA INC. (4-1250 Waverley StreetWinnipeg, Manitoba R3T 6C6) filed a patent application (PCT/CA2024/051581) for "QUINAZOLINONE DERIVATIVES AS POLY (ADP RIBOSE) POLYMERASE 1 (PARP-1) INHIBITORS" on Nov 28, 2024. With publication no. WO/2025/111705, the details related to the patent application was published on Jun 05, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): TWIBANIRE, Jean-d'amour Karemerwa (c/o Waverley Pharma Inc., 4-1250 Waverley StreetWinnipeg, Manitoba R3T 6C6), COOK, Cyril (c/o Waverley Pharma Inc., 4-1250 Waverley StreetWinnipeg, Manitoba R3T 6C6), ...